Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Narcan, the nasal spray version of naloxone, has received F.D.A. approval to be sold over the counter.
- Simplified Text
-
The FDA has approved the naloxone nasal spray Narcan for over-the-counter sale.
- Confidence Score
- 1.000
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "product": "Narcan", "organization": "F.D.A." } - Subject Tags
- UUID
- 0a50b6af-bce9-4a56-9857-7e25aba4acf0
- Vector Index
- âś— No vector
- Created
- September 17, 2026 at 8:15 PM (3 weeks ago)
- Last Updated
- September 17, 2026 at 8:15 PM (3 weeks ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
21
claims
🔥
3 weeks ago
https://nytimes.com/2026/09/16/us/uss-abraham-lincoln-fentanyl.html
Two former U.S. Navy service members pleaded guilty to selling fentanyl-laced counterfeit oxycodone pills to active-duty sailors, including during deployments. One sailor died from an overdose, and another was hospitalized.
Similar Claims (5)
Other claims identified as semantically similar to this one.
-
Simplified: FDA approved Novo Nordisk's Wegovy to reduce risk of major cardiovascular deaths in people with heart disease7 months ago
-
Simplified: The F.D.A. narrowed approval of Covid shots for the season that began last fall7 months ago
-
Simplified: The FDA's investigational device program granted permission for the Paradromics clinical trial.3 weeks ago
-
Simplified: US drug overdose deaths reached record highs in 2021, largely due to fentanyl.3 weeks ago
-
Simplified: The Department of Health and Human Services, overseen by Secretary Robert F. Kennedy Jr., is reviewing at least one ketamine therapy for approval.2 weeks ago